Multidrug-resistant.
Belonging to European clone II, was widely spread in China.
Isolated from the bloodstream of a patient hospitalized in the intensive care unit of the first affiliated hospital at Zhejiang University in Hangzhou, China on 20 April 2006. The patient suffered from acute exacerbations of chronic obstructive pulmonary disease, respiratory failure, and ventilator-associated pneumonia (VAP).